Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders

Journal of Clinical Oncology

Volumn 24, Issue 6, 2006, Pages 983-987

  Novak, Anne J ^a   Grote, Deanna M ^a   Ziesmer, Steven C ^a   Kline, Michael P ^a   Manske, Michelle K ^a   Slager, Susan ^a   Witzig, Thomas E ^a   Shanafelt, Tait ^a   Call, Timothy G ^a   Kay, Neil E ^a   Jelinek, Diane F ^a   Cerhan, James R ^a   Gross, Jane A ^a   Harder, Brandon ^a   Dillon, Stacey R ^a   Ansell, Stephen M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4 ANTIBODY; LUCIFERASE; B CELL ACTIVATING FACTOR; MEMBRANE PROTEIN; TNFSF13B PROTEIN, HUMAN; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; CANCER CENTER; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; GENE CONSTRUCT; GENE SEQUENCE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FOLDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; B CELL LYMPHOMA; BLOOD; CASE CONTROL STUDY; CELL STRAIN HL 60; CHRONIC LYMPHATIC LEUKEMIA; DNA SEQUENCE; GENETICS; MIDDLE AGED;

ADULT; AGED; B-CELL ACTIVATING FACTOR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, B-CELL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644913405     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.7938     Document Type: Article

References (24)

1. Moore PA, Belvedere O, Orr A, et al: BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260-263, 1999
2. Schneider P, MacKay F, Steiner V, et al: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747-1756, 1999
3. Mukhopadhyay A, Ni J, Zhai Y, et al: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 274:15978-15981, 1999
4. Shu HB, Hu WH, Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65:680-683, 1999
5. Gross JA, Johnston J, Mudri S, et al: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995-999, 2000
6. Mackay F, Woodcock SA, Lawton P, et al: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697-1710, 1999
7. Do RK, Hatada E, Lee H, et al: Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 192:953-964, 2000
8. Khare SD, Sarosi I, Xia XZ, et al: Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 97:3370-3375, 2000
9. Novak AJ, Bram RJ, Kay NE, et al: Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: A mechanism for survival. Blood 100:2973-2979, 2002
10. Novak AJ, Darce JR, Arendt BK, et al: Expression of BCMA, TACI, and BAFF-R in multiple myeloma: A mechanism for growth and survival. Blood 103:689-694, 2004
11. Novak AJ, Grote DM, Stenson M, et al: Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: Correlation with disease activity and patient outcome. Blood 104:2247-2253, 2004
12. Kern C, Cornuel JF, Billard C, et al: Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103:679-688, 2004
13. Briones J, Timmerman JM, Hilbert DM, et al: BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol 30:135-141, 2002
14. Moreaux J, Legouffe E, Jourdan E, et al: BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103:3148-3157, 2004
15. Scapini P, Nardelli B, Nadali G, et al: G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 197:297-302, 2003
16. Nardelli B, Belvedere O, Roschke V, et al: Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198-204, 2001
17. Craxton A, Magaletti D, Ryan EJ, et al: Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101:4464-4471, 2003
18. He B, Chadburn A, Jou E, et al: Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 172:3268-3279, 2004
19. Shanafelt TD, Geyer SM, Kay NE: Prognosis at diagnosis: Integrating molecular biologic insights into clinical practice for patients with CLL. Blood 103:1202-1210, 2004
20. Rai KR, Sawitsky A, Cronkite EP, et al: Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234, 1975
21. Kawasaki A, Tsuchiya N, Fukazawa T, et al: Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 3:424-429, 2002
22. Catovsky D: The search for genetic clues in chronic lymphocytic leukemia. Hematol Cell Ther 39:S5-S11, 1997 (suppl 1)
23. Jiang Y, Ohtsuji M, Abe M, et al: Polymorphism and chromosomal mapping of the mouse gene for B-cell activating factor belonging to the tumor necrosis factor family (Baff) and association with the autoimmune phenotype. Immunogenetics 53:810-813, 2001
24. Morris JF, Hromas R, Rauscher FJ III: Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol Cell Biol 14:1786-1795, 1994